secwatch.observer — SEC 8-K summary
======================================

Issuer:     NexImmune, Inc. (—)
CIK:        0001538210
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0001193125-23-269502
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

NexImmune board approves dissolution plan and reduction-in-force of substantially all employees
--------------------------------------------------------------------------------

- Board unanimously approved liquidation and dissolution, subject to stockholder approval, on November 2, 2023.
- Reduction-in-force of substantially all employees approved October 31, 2023; only key management retained for wind-down.
- Company will call a special stockholder meeting to vote on dissolution; proxy materials to be filed.
- Reduction-in-force expected to be substantially complete in November 2023; cost estimate not yet determinable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1538210/000119312523269502/0001193125-23-269502-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1538210/000119312523269502/d376920d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-269502

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer